GlaxoSmithKline Pharmaceuticals Limited announced the appointment of Manu Anand as Additional Director on the Board of the company, with effect from May 16, 2022. According to the company’s exchange filing, “Pursuant to Regulation 30 and Schedule Ill (A) (7) of the Listing and Disclosure Requirements Regulations, 2015, we wish to inform you that Board of…
GlaxoSmithKline Pharmaceuticals Limited announced the re-appointment of Sridhar Venkatesh as Managing Director of the company for a period of one year from 1st April 2022 to 31st March 2023. Sridhar Venkatesh is a senior business leader with more than 28 years of diverse experience in pharmaceuticals and healthcare. He joined GSK in 2011 as Head…
GlaxoSmithKline Pharmaceuticals Limited announced its decision to transfer its rights in relation to the Iodex and Ostocalcium brands to GlaxoSmithKline Asia Private Limited, subject to shareholder approval, for an aggregate consideration of Rs 1649 crores. The company also declared its financial results for the quarter ended June 30, 2021. Revenue for the quarter came in…
CureVac, a leading clinical stage biotechnology company in the field of messenger RNA and one of Germany’s leading contenders to develop a COVID-19 vaccine, said it aims to raise up to $245 million in an initial public offering (IPO) on the US Nasdaq, according to Reuters. The biotech firm said it plans to offer a…
GlaxoSmithKline, a British multinational pharmaceutical company, announced that it has sold its stake in Unilever’s Indian business for $3.35 billion. The funds will help GSK in its goal of reinvigorating its drug development pipeline, having made costly bets on experimental cancer treatments and future cell and gene therapies amid sluggish revenue growth. The 133.77 million…